Latest Market News

Page 563 of 1876
CD Private Equity Fund II reported a reduced net loss of $2.43 million for the half-year to September 2025, supported by $9.45 million in distributions from portfolio realisations. Despite foreign exchange headwinds, the Fund maintains a diversified portfolio and a positive long-term return track record.
Victor Sage
Victor Sage
28 Nov 2025
CD Private Equity Fund I reported a $2.6 million net loss for the half-year ended 30 September 2025, driven by foreign exchange impacts and fair value adjustments, while distributing 8 cents per unit amid ongoing portfolio realisations.
Victor Sage
Victor Sage
28 Nov 2025
TruScreen Group Limited reported a 17% decline in first half FY2026 product sales but affirmed full-year revenue guidance at NZ$2.8 million, supported by strategic expansions and a successful NZ$4 million capital raise.
Ada Torres
Ada Torres
28 Nov 2025
Vysarn Limited has reported record FY25 profits and is aiming for a 33% NPBT increase in FY26, driven by acquisitions and progress on the Kariyarra Water Scheme. The company is expanding its national footprint amid growing water demand in mining and infrastructure sectors.
Victor Sage
Victor Sage
27 Nov 2025
Coronado Global Resources has finalized its financial support agreement with Stanwell Corporation, cementing previously disclosed terms and providing clarity on its capital position.
Maxwell Dee
Maxwell Dee
27 Nov 2025
VEEM Limited reported a year of consolidation in FY25 with solid second-half growth driven by new defence contracts and the promising launch of its VEEM Extreme propulsion system. Despite a revenue dip, the company is poised for a stronger FY26 backed by strategic US defence partnerships and product innovation.
Victor Sage
Victor Sage
27 Nov 2025
Joyce Group reported solid FY25 results with strong revenue growth and a 20% expansion in KWB showrooms, alongside a key leadership transition at KWB.
Logan Eniac
Logan Eniac
27 Nov 2025
Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.
Ada Torres
Ada Torres
27 Nov 2025
The Federal Court of Australia has approved the acquisition scheme for Lynch Group Holdings, paving the way for a cash payout to shareholders and imminent trading suspension.
Victor Sage
Victor Sage
27 Nov 2025
QGold Pty Ltd has initiated an unconditional on-market takeover offer for all shares in Venus Metals Corporation Limited at a 21% premium, aiming to consolidate control and potentially delist the explorer.
Maxwell Dee
Maxwell Dee
27 Nov 2025
QGold Pty Ltd has launched an unconditional on-market takeover offer for all shares of Venus Metals Corporation Limited at a 21% premium, providing shareholders with immediate cash liquidity. The offer, backed by a substantial funding arrangement, signals potential strategic shifts for Venus Metals.
Maxwell Dee
Maxwell Dee
27 Nov 2025
QGold Pty Ltd has initiated an unconditional on-market takeover offer for all remaining shares of Venus Metals Corporation at $0.17 per share, aiming to consolidate control by mid-January 2026.
Maxwell Dee
Maxwell Dee
27 Nov 2025